- Business
- KKR & Co. Inc. (NYSE: KKR; KKR-PC) operates as a leading global investment firm that manages alternative assets including private equity, real assets encompassing infrastructure and real estate, credit, capital markets solutions, and insurance products through its Global Atlantic subsidiary; the firm also maintains strategic holdings in core private equity strategies and provides investment management services to funds, vehicles, and accounts across public and private markets. Founded in 1976 by Jerome Kohlberg, Jr., Henry Kravis, and George R. Roberts in New York City, KKR & Co. Inc. is headquartered at 30 Hudson Yards in Manhattan, New York, with extensive global operations through offices in key financial centers such as Beijing, Dubai, Dublin, Houston, Hong Kong, London, Luxembourg, Madrid, Menlo Park, Mumbai, Paris, Riyadh, San Francisco, São Paulo, Seoul, Singapore, Shanghai, Sydney, and Tokyo, serving institutional investors, high-net-worth individuals, corporations, and governments worldwide. The company's asset management segment features dedicated lines for private equity focused on growth capital, buyouts, and operational enhancements; real assets including diverse property types for income and appreciation as well as infrastructure in transportation, energy, and utilities; credit offerings like leveraged loans, high-yield bonds, direct lending, and liquid strategies; capital markets services for portfolio companies and third parties; alongside principal activities and hedge fund partnerships employing long-short equity, macro, and multi-strategy approaches. In recent developments, KKR & Co. Inc. agreed to acquire post-trade services provider OSTTRA for $3.1 billion and launched a $1.22 billion offer for Swedish biotech firm Biotage in April 2025 to bolster financial technology and life sciences presence; the firm secured majority ownership in healthcare royalty investor HealthCare Royalty Partners in August 2025, expanding its healthcare portfolio; it provided a $300 million credit facility to solar developer Ecoplexus for over 13 gigawatts of U.S. renewable energy projects, advanced a strategic partnership expansion with Capital Group for public-private retirement and wealth solutions including new funds, and initiated fundraising for its fifth Asia private equity fund targeting $15 billion as of late 2025; earlier transactions encompassed 2024 acquisitions of Karo Healthcare for €2.6 billion, Superstruct Entertainment, Datagroup SE, The Parking Spot, Rebel Foods, CLEAResult Consulting, and GeoStabilization International across healthcare, entertainment, IT, transportation, food services, energy efficiency, and infrastructure, alongside 2023 deals for Simon & Schuster at $1.62 billion and FGS Global majority stake at $1.7 billion.